Executive summary: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America

Clinical Infectious Diseases

Volumn 52, Issue 4, 2011, Pages 427-431

  Freifeld, Alison G ^a   Bow, Eric J ⁱ   Sepkowitz, Kent A ^b   Boeckh, Michael J ^d   Ito, James I ^e   Mullen, Craig A ^c   Raad, Issam I ^f   Rolston, Kenneth V ^f   Young, Jo Anne H ^g   Wingard, John R ^h  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; AMINOTRANSFERASE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BILIRUBIN; CARBAPENEM; CASPOFUNGIN; CEFEPIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CREATININE; FLUCONAZOLE; ITRACONAZOLE; LEVOFLOXACIN; MEROPENEM; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIALIDASE INHIBITOR; VANCOMYCIN; VORICONAZOLE;

ABDOMINAL PAIN; ADENOVIRUS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPERGILLOSIS; BLOOD CELL COUNT; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANDIDIASIS; COMMON COLD; COUGHING; CREATININE BLOOD LEVEL; FEVER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INFECTION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; LEUKEMIA; LEUKOCYTE COUNT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOSIS; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; NEOPLASM; NEUTROPENIA; NEUTROPHIL COUNT; PARAINFLUENZA VIRUS INFECTION; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; VANCOMYCIN RESISTANT ENTEROCOCCUS; ARTICLE; CANADA; CHEMICALLY INDUCED DISORDER; COMMUNICABLE DISEASE; PYREXIA IDIOPATHICA; UNITED STATES;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CANADA; COMMUNICABLE DISEASES; FEVER OF UNKNOWN ORIGIN; HUMANS; NEOPLASMS; NEUTROPENIA; UNITED STATES;

EID: 79951836108     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq147     Document Type: Review

References (0)